Develops nitric oxide delivery devices and research systems for hospitals, clinics, laboratories, and other medical users; also explores and develops gold properties.
10-K for FY2025, filed Apr 15, 2026 8-K, filed Jul 10, 2026NU-MED was organized as a medical device company principally engaged in the design, innovation, development, enhancement and…View ↗
2. A hospital delivery device with controls and safety monitors built in that delivers inhaled nitric oxide to a patient at therapeutic…View ↗
Reagent Delivery. During development of the Nu-Med line of medical nitric oxide delivery systems it was discovered that a system could be…View ↗
Nu-Med Plus, Inc. is a Utah company whose shares are quoted on the OTCQB Venture Market. Following the acquisition of Avid Gold Ltd, Nu-Med…View ↗
No revenue reported yet.
10-K for FY2020, filed Mar 31, 2021
Its planned nitric oxide devices are intended for hospitals and clinics, while its research delivery system serves laboratories and the research community.
10-K for FY2025, filed Apr 15, 20262. A hospital delivery device with controls and safety monitors built in that delivers inhaled nitric oxide to a patient at therapeutic…View ↗
Clinical Delivery System. The clinical system is a simplified version of the hospital unit. While it can be used in a hospital setting it…View ↗
Reagent Delivery. During development of the Nu-Med line of medical nitric oxide delivery systems it was discovered that a system could be…View ↗
10-Q for Q2 FY2026, filed Aug 14, 2026
$19.7KView ↗
8-K, filed Aug 25, 2026
On the Closing Date, the Company, through MGC, completed the Purchase and acquired a 100% beneficial interest in the Properties and their…View ↗
8-K, filed Jul 10, 2026
NU-Med Plus Announces Acquisition of Avid Gold and Agreement to Acquire Canadian Gold PropertiesView ↗
Gold exploration added
The latest report describes a nitric oxide medical-device development business. The company then added Avid Gold and gold exploration and development, alongside its medical-device business.
10-K for FY2022, filed Mar 29, 2023 10-K for FY2025, filed Apr 15, 2026 8-K, filed Jul 10, 2026NU-MED was organized as a medical device company principally engaged in the design, innovation, development, enhancement and…View ↗
NU-MED was organized as a medical device company principally engaged in the design, innovation, development, enhancement and…View ↗
Nu-Med Plus, Inc. is a Utah company whose shares are quoted on the OTCQB Venture Market. Following the acquisition of Avid Gold Ltd, Nu-Med…View ↗
Competes with Mallinckrodt, GeNO, and Beyond Air
10-K for FY2025, filed Apr 15, 2026Mallinckrodt Inc. acquired the company which, at that time, had the only FDA approved nitric oxide (INOMAX) delivery system for use in…View ↗
Loading...